Case Activity (625)

1. Filed: September 14, 2026 | Entered: September 14, 2026 United States of America et al v. Regeneron Pharmaceuticals, Inc. et al

   Qui Tam (31 U.S.C. § 3729(a)) | California Central

   Text Only Scheduling Notice

   (IN CHAMBERS) ORDER by Judge John W. Holcomb: In view of the Ninth Circuit Mandate [ECF No. 161] issued on September 10, 2026, the Court hereby ORDERS as follows: (1) the parties are DIRECTED to confer FORTHWITH and to file no later than October 2, 2026, a Joint Status Report that provides the Court with the parties' respective views on an appropriate case schedule in view of the Ninth Circuit's memorandum disposition [ECF No. 160] of the appeal; and (2) a Scheduling Conference is SET for October 16, 2026, at 11:00 a.m. Counsel for the parties are DIRECTED to appear in person at that time in Courtroom 9D, on the 9th Floor of the Ronald Reagan Federal Building and the United States Courthouse at 411 W. Fourth Street Santa Ana, California. IT IS SO ORDERED.THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (cla) TEXT ONLY ENTRY

2. Appeal | Filed: September 10, 2026 | Entered: September 12, 2026 United States of America et al v. Regeneron Pharmaceuticals, Inc. et al

   Qui Tam (31 U.S.C. § 3729(a)) | California Central

   USCA Mandate

   MANDATE of Ninth Circuit Court of Appeals filed re: USCA Memorandum/Opinion/Order, 160 , CCA # 24-5569. The judgment of this Court, entered August 19, 2026, takes effect this date. This constitutes the formal mandate of this Court issued pursuant to Rule 41(a) of the Federal Rules of Appellate Procedure. (san)

3. 623 additional result(s)